Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q4 2025 earnings summary

Executive summary

• Net turnover for 2025 reached €1.94 million, up 17.3% year-over-year, driven by increased genetics industry sales.

• Profit for 2025 was €29.1 thousand, a decrease of €51.7 thousand compared to 2024.

• No significant impact from the Russia-Ukraine war or other major events on operations or financials.

• Board proposes paying €33,795.20 in dividends from retained earnings, €0.08 per share.

Financial highlights

• Net sales: €1,942,891 in 2025 vs. €1,656,333 in 2024.

• Profit before tax: €31,080; profit after tax: €29,111 in 2025.

• Earnings per share (EPS): €0.069 in 2025, down from €0.191 in 2024.

• Cash at year-end: €135,487, up from €82,385 in 2024.

Outlook and guidance

• Focus remains on expanding market size and increasing operational efficiency.

• No significant post-balance-sheet events or changes in risk outlook.